相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemokine Receptors as Targets for Cancer Therapy
Xuesong Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
A complex pattern of chemokine receptor expression is seen in osteosarcoma
Irene von Luettichau et al.
BMC CANCER (2008)
The role of CXC chemokines and their receptors in cancer
Jo Vandercappellen et al.
CANCER LETTERS (2008)
The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis
S. Gellmini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
CXCR4 Receptor as a Promising Target for Oncolytic Drugs
Yan Lavrovsky et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases
Su Young Kim et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Platelet-associated PF-4 as a biomarker of early tumor growth
David Cervi et al.
BLOOD (2008)
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Ilona Kryczek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Functions of CXCL12 and CXCR4 in breast cancer
Kathryn E. Luker et al.
CANCER LETTERS (2006)
Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1β and hypoxia in small cell lung cancer
Y. M. Zhu et al.
BRITISH JOURNAL OF CANCER (2006)
CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis
Y Oda et al.
MODERN PATHOLOGY (2006)
Cancer CXC chemokine networks and tumour angiogenesis
RM Strieter et al.
EUROPEAN JOURNAL OF CANCER (2006)
Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1α
RJ Phillips et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer
TT Maliekal et al.
ONCOGENE (2003)
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide
G Bacci et al.
ANNALS OF ONCOLOGY (2003)
Primary metastatic osteosarcoma:: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome
LL Wang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle
E Van Coillie et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
JM Birch et al.
ONCOGENE (2001)
分享论文
